Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy
- 1 September 2013
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 27 (5) , 463-466
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancerBritish Journal of Cancer, 2012
- Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanismsWorld Journal of Gastroenterology, 2011
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthaseEndocrine-Related Cancer, 2010
- Why diabetes patients are more prone to the development of colon cancer?Medical Hypotheses, 2008
- Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in KoreaDiseases of the Colon & Rectum, 2008
- Type 2 diabetes mellitus as risk factor for colorectal cancerArchives of Physiology and Biochemistry, 2008
- Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell GrowthCancer Research, 2007
- Type 2 Diabetes Mellitus: The Impact on Colorectal Adenoma Risk in WomenAmerican Journal of Gastroenterology, 2006
- Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidenceGut, 2001
- Mechanisms Linking Diet and Colorectal Cancer: The Possible Role of Insulin ResistanceNutrition and Cancer, 2000